Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.52 |
| ▸ | NT5E | P21589 | 3/20 | 0.52 |
| ▸ | CASP6 | P55212 | 3/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | NSD2 | O96028 | 2/20 | 0.48 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11331642 | 0.98 | ALDH1A1 (0.50) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL176914 | 0.90 | CASR (0.45) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL7709568 | 0.89 | NT5E (0.47) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL5499800 | 0.87 | NT5E (0.46) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL9337500 | 0.87 | ALDH1A1 (0.49) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL17262954 | 0.87 | ALDH1A1 (0.60) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL8635234 | 0.84 | ALDH1A1 (0.42) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL21589353 | 0.80 | NT5E (0.47) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL9336949 | 0.80 | ALDH1A1 (0.54) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 | |
| SCHEMBL21589346 | 0.80 | ALDH1A1 (0.56) | ALDH1A1HSD17B10NT5ECASP6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549504-A | Efficient train cleaning agent containing polyimide and preparation method thereof | 成都普利美特科技有限公司 | 2021-10-26 | — | — | CN | claimed |
| CN-112962307-A | Thermal fabric and preparation method thereof | 杨含江 | 2021-06-15 | — | — | CN | claimed |
| CN-112941901-A | Warm-keeping and comfortable child fabric | 杨含江 | 2021-06-11 | — | — | CN | claimed |
| US-20250221408-A1 | COMPOSITION | EARTH CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| CN-119114152-A | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2024-12-13 | — | — | CN | disclosed |
| EP-4473837-A1 | COMPOSITION | Earth Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| CN-118956177-A | Reactive dye with ultrahigh fixation rate and ultrahigh color fastness for printing and pad dyeing, and preparation method and application thereof | 南京晓庄学院 | 2024-11-15 | — | — | CN | disclosed |
| CN-118695780-A | Composition and method for producing the same | 阿斯制药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| CN-110769931-B | Free radical generating catalyst, method for producing free radical, method for producing oxidation reaction product, pharmaceutical agent, and agricultural and livestock pharmaceutical agent | 株式会社ACENET | 2024-09-17 | — | — | CN | disclosed |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | ACENET INC. (JP) | 2024-01-04 | — | — | US | disclosed |
| US-20230263710-A1 | ORAL CARE AGENT | OSAKA UNIVERSITY (JP) | 2023-08-24 | — | — | US | disclosed |
| US-4144231-A | Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component | CASSELLA AKTIENGESELLSCHAFT (DE) | 1979-03-13 | — | — | US | disclosed |
| US-4144230-A | Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component | CASSELLA AKTIENGESELLSCHAFT (DE) | 1979-03-13 | — | — | US | disclosed |
| US-4133943-A | DIAMINOAROMATIC CARBOXYLIC OR SULFONIC ACIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-09 | — | — | US | disclosed |
| US-4120893-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4083845-A | DYEING CELLULOSE FIBER | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-11 | — | — | US | disclosed |
| US-4051134-A | Reactive dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4043997-A | Method for isolating albumin using insoluble supports coupled to a dye | CUTTER LABORATORIES, INC. (US) | 1977-08-23 | — | — | US | disclosed |
| US-4033946-A | Tetrakisazo dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-05 | — | — | US | disclosed |
| US-3966703-A | Asymmetrical frisazo dyestuffs derived from diazotized 2,7-diamino-carbazole | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263710-A1 | ORAL CARE AGENT | TAS2R39, TAS2R40, TAS2R45 | ALDH1A1 2248/4885HSD17B10 4035/4885NT5E 2660/4885 |
| US-20240000084-A1 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | EIF2AK2, HAO2, ZC3HAV1 | ALDH1A1 1641/4885HSD17B10 2328/4885NT5E 3141/4885 |
| US-20250221408-A1 | COMPOSITION | GGPS1, PGGT1B, HBG2 | ALDH1A1 1071/4885HSD17B10 47/4885NT5E 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.